Proposal for a new morphological “combined type” of gallbladder cancer: description of radiopathological characteristics and comparison with other morphological types
To describe the radiopathological characteristics of a new morphological “combined type” of gallbladder cancer (GBC) and compare it with the mass replacing gallbladder and thickening types of GBC.
Materials and methods
The imaging and pathological details of consecutive patients with GBC between August 2020 and December 2022 were retrospectively reviewed. Two radiologists reviewed computed tomography/magnetic resonance imaging in consensus for the morphological type of GBC. The radiologists classified GBC as mass replacing gallbladder, wall thickening, and combined type. The combined type was defined as a mass arising from the thickened wall of an adequately distended gallbladder that extended exophytically into the adjacent liver parenchyma. The presence of calculi, site, and size of lesion, biliary/portal vein involvement, liver, lymph node, and omental metastases was compared among the various types. The pathological characteristics were also compared.
Results
Of the 481 patients (median age 55 years, 63.2% females) included in the study, mass replacing gallbladder, wall thickening, and combined-type GBC were seen in 42.8% (206/481), 40.5% (195/481), and 16.6% (80/481) of patients, respectively. In the combined type of GBC, biliary/portal vein involvement was seen in 63.7% (51/80) and 7.5% (6/80) of patients. Liver, lymph node, and omental metastases were seen in 67.5% (54/80), 40% (32/80), and 41.2% (33/80) patients, respectively. Liver metastases were significantly more common in the combined type (p = 0.002). There were no significant differences in pathological characteristics among the various types.
Conclusion
Combined-type GBC is less common than the mass replacing gallbladder and thickening types and is associated with a higher risk of liver metastases.
Proposal for a new morphological “combined type” of gallbladder cancer: description of radiopathological characteristics and comparison with other morphological types
Authors
Manika Chhabra Daneshwari Kalage Pankaj Gupta Ruby Siddiqui Shravya Singh Thakur Deen Yadav Vikas Gupta Lileswar Kaman Harjeet Singh Santosh Irrinki Chandan Das Gaurav Prakash Parikshaa Gupta Uma Nahar Saikia Ritambhra Nada Usha Dutta Manavjit Singh Sandhu
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.